Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pfizer Inc (PFE) vs Xpeng Inc - ADR (XPEV) Price & Performance

Pfizer IncTrade
Xpeng Inc - ADRTrade

Price performance (Past 24H)

Key statistics

Pfizer Inc vs Xpeng Inc - ADR — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Xpeng Inc - ADR trades at $12.83 (market cap $12.66B). The key difference: Pfizer Inc is far larger — about 11.2× Xpeng Inc - ADR's market cap, and Pfizer Inc pays a 6.9% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.

PFEXPEV
Market Cap
$142.14B$12.66B
Volume
29,869,932
Sector
HealthConsumer Cyclical
52-Week High
$28.56$28.07
52-Week Low
$23.29$12.09
Enterprise Value
$192.80B$14.78B
Dividend Yield
6.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Pfizer Inc

Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.

PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.

Xpeng Inc - ADR

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE

About Xpeng Inc - ADR

Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Read more on XPEV